Claudin expression profile in flat wart and cutaneous squamous cell carcinoma in epidermodysplasia verruciformis

Imagem de Miniatura
Arquivos
art_SILVA_Claudin_expression_profile_in_flat_wart_and_cutaneous_2020.PDF (2.72 MB)
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2020
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
NATURE PUBLISHING GROUP
Autores
TANABE, Claudia Kwei-Fong Dai
MATTOS, Mayra Servilha Grion
Citação
SCIENTIFIC REPORTS, v.10, n.1, article ID 9268, 11p, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Epidermodysplasia verruciformis (EV) is a genodermatosis related to human beta-papillomavirus (beta-HPV), with a high risk of cutaneous squamous cell carcinoma (cSCC). Claudins are transmembrane proteins expressed in epithelia and may be altered during carcinogenesis. For a better understanding of the role of beta-HPV in cutaneous carcinogenesis, this claudin expression study was conducted on lesions of patients with and without EV. In this study, claudins-1, -2, -3, -4, -5, -7 and -11 expressions were analyzed by applying the immunohistochemistry technique, in samples of 108 normal skin, 39 flat warts and 174 cSCC. The cSCC samples were organized in tissue microarrays. We found that claudin-1 and claudin-3 focal expressions were associated with cSCC (p<0.001), and claudin-2 focal or negative expression with flat wart (p<0.001), in EV and NEV (non-EV) groups. For claudin-5, EV group showed a lower chance of focal and negative expression (p<0.001), and its negative expression was associated with flat wart (p<0.001) and lower mean age (p<0.001). Claudins-4, -7 and -11 showed a diffuse expression in almost all studied samples. Our findings suggest that claudin-5 increased expression observed on normal skin, flat wart and cSCC showed association with EV. Claudin-1 and -3 down expression were also observed, but they could not be related to beta-HPV infection.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/37011
Referências
  1. Agarwal R, 2005, CANCER RES, V65, P7378, DOI 10.1158/0008-5472.CAN-05-1036
  2. Akgul B, 2005, CANCER RES, V65, P2216, DOI 10.1158/0008-5472.CAN-04-1952
  3. Angelow S, 2008, AM J PHYSIOL-RENAL, V295, pF867, DOI 10.1152/ajprenal.90264.2008
  4. Angelow S, 2007, CURR OPIN NEPHROL HY, V16, P459, DOI 10.1097/MNH.0b013e32820ac97d
  5. Arabzadeh A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-196
  6. Barcelos ACN, 2009, J CUTAN PATHOL, V36, P647, DOI 10.1111/j.1600-0560.2008.01127.x
  7. Bello IO, 2008, HUM PATHOL, V39, P1212, DOI 10.1016/j.humpath.2007.12.015
  8. Blackman B, 2005, BREAST CANCER RES, V7, pR248, DOI 10.1186/bcr988
  9. Brandner JM, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.974451
  10. Brandner JM, 2009, EUR J PHARM BIOPHARM, V72, P289, DOI 10.1016/j.ejpb.2008.08.007
  11. Chiba T, 2010, DIS ESOPHAGUS, V23, P398, DOI 10.1111/j.1442-2050.2009.01023.x
  12. D'Souza T, 2005, J BIOL CHEM, V280, P26233, DOI 10.1074/jbc.M502003200
  13. de Oliveira WRP, 2004, J CUTAN MED SURG, V8, P110, DOI 10.1177/120347540400800206
  14. de Oliveira WRP, 2003, J EUR ACAD DERMATOL, V17, P394, DOI 10.1046/j.1468-3083.2003.00703.x
  15. Ding Lei, 2013, Cancer Manag Res, V5, P367, DOI 10.2147/CMAR.S38294
  16. Escudero-Esparza A, 2011, FRONT BIOSCI-LANDMRK, V16, P1069, DOI 10.2741/3736
  17. Gul U, 2007, INT J DERMATOL, V46, P1069, DOI 10.1111/j.1365-4632.2006.03014.x
  18. Heuser S, 2016, J GEN VIROL, V97, P463, DOI 10.1099/jgv.0.000363
  19. Hintsala HR, 2013, INT J CLIN EXP PATHO, V6, P2855
  20. Jablonska S, 1994, Curr Top Microbiol Immunol, V186, P157
  21. Jung JH, 2009, PATHOL RES PRACT, V205, P409, DOI 10.1016/j.prp.2008.12.015
  22. Kojima F, 2010, ONCOL REP, V23, P927, DOI 10.3892/or_00000716
  23. Kondoh A, 2011, ACTA OTO-LARYNGOL, V131, P861, DOI 10.3109/00016489.2011.562537
  24. Lee JS, 2019, CLIN EXP DERMATOL, V44, P483, DOI 10.1111/ced.13810
  25. Lourenco SV, 2010, J CLIN PATHOL, V63, P609, DOI 10.1136/jcp.2009.070409
  26. MAJEWSKI S, 1995, ARCH DERMATOL, V131, P1312, DOI 10.1001/archderm.131.11.1312
  27. Melchers LJ, 2013, ORAL ONCOL, V49, P998, DOI 10.1016/j.oraloncology.2013.07.008
  28. Miettinen M, 2011, AM J SURG PATHOL, V35, P1848, DOI 10.1097/PAS.0b013e318229a401
  29. Mineta K, 2011, FEBS LETT, V585, P606, DOI 10.1016/j.febslet.2011.01.028
  30. Miyamori H, 2001, J BIOL CHEM, V276, P28204, DOI 10.1074/jbc.M103083200
  31. Miyamoto K, 2008, BIOMED RES-TOKYO, V29, P71, DOI 10.2220/biomedres.29.71
  32. Morin PJ, 2005, CANCER RES, V65, P9603, DOI 10.1158/0008-5472.CAN-05-2782
  33. Morita K, 2004, BRIT J DERMATOL, V151, P328, DOI 10.1111/j.1365-2133.2004.06029.x
  34. Morita K, 2003, EXP DERMATOL, V12, P289, DOI 10.1034/j.1600-0625.2003.120309.x
  35. Morohashi S, 2007, INT J MOL MED, V20, P139
  36. Nissinen L, 2017, EXP DERMATOL, V26, P771, DOI 10.1111/exd.13278
  37. O'Neill CA, 2011, EXP DERMATOL, V20, P88, DOI 10.1111/j.1600-0625.2010.01206.x
  38. Oku N, 2006, CANCER RES, V66, P5251, DOI 10.1158/0008-5472.CAN-05-4478
  39. Oliveira WR, 2006, J EUR ACAD DERMATOL, V20, P1154, DOI 10.1111/j.1468-3083.2006.01654.x
  40. Orth G, 2006, SEMIN IMMUNOL, V18, P362, DOI 10.1016/j.smim.2006.07.008
  41. Osanai M, 2017, PFLUG ARCH EUR J PHY, V469, P55, DOI 10.1007/s00424-016-1877-7
  42. Ouban A, 2012, INT J SURG PATHOL, V20, P132, DOI 10.1177/1066896911424488
  43. Peltonen S, 2007, BRIT J DERMATOL, V156, P466, DOI 10.1111/j.1365-2133.2006.07642.x
  44. Potenza C, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9489163
  45. Riski M, 2012, TUMOR BIOL, V33, P537, DOI 10.1007/s13277-011-0289-8
  46. Rollison DE, 2019, J VIROL, V93, DOI 10.1128/JVI.01003-18
  47. Sadalla JC, 2011, J CLIN PATHOL, V64, P853, DOI 10.1136/jclinpath-2011-200103
  48. Silva L L D. C, 2019, THESIS
  49. Soini Y, 2005, HISTOPATHOLOGY, V46, P551, DOI 10.1111/j.1365-2559.2005.02127.x
  50. Soini Y, 2004, HUM PATHOL, V35, P1531, DOI 10.1016/j.humpath.2004.09.015
  51. Soini Y, 2006, INT J GYNECOL PATHOL, V25, P330, DOI 10.1097/01.pgp.0000215298.38114.cc
  52. Takala H, 2007, APMIS, V115, P838, DOI 10.1111/j.1600-0463.2007.apm_656.x
  53. Todd MC, 2015, ONCOL LETT, V10, P156, DOI 10.3892/ol.2015.3160
  54. Usami Y, 2006, HUM PATHOL, V37, P569, DOI 10.1016/j.humpath.2005.12.018
  55. Yigit N, 2016, ANN DIAGN PATHOL, V20, P44, DOI 10.1016/j.anndiagpath.2015.10.005
  56. Yuki T, 2011, J INVEST DERMATOL, V131, P744, DOI 10.1038/jid.2010.385
  57. Zhang WN, 2016, ONCOTARGET, V7, P87449, DOI 10.18632/oncotarget.13871

Coleções
Artigos e Materiais de Revistas Científicas - FM/MPT
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - IMT
Artigos e Materiais de Revistas Científicas - LIM/53
Artigos e Materiais de Revistas Científicas - ODS/03